A team led by investigators from Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, used a new drug to save the life of a patient with immune thrombotic thrombocytopenic purpura (iTTP), a rare disorder characterized by uncontrolled clotting throughout the small blood vessels.
MGH investigators use new drug to save the life of patient with immune thrombotic thrombocytopenic purpura
- Thread starter Educator
- Start date